Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Subscribe Search Contacts Login 
  • Users Online: 192
  • Home
  • Print this page
  • Email this page
RESEARCH ARTICLE
Year : 2012  |  Volume : 24  |  Issue : 4  |  Page : 269-273

Evaluation of efficacy of tacrolimus 0.1% in orabase and triamcinolone acetonide 0.1% in orabase in the management of symptomatic oral lichen planus randomized single blind control study


1 Assistant Professor, Department of Oral Medicine and Radiology, College of Dental Sciences, Davangere, Kamataka, India
2 Professor and Head, Department of Oral Medicine and Radiology, SDM College of Dental Sciences, Dhanvad. Kamataka, India
3 Professor, Department of Oral Medicine and Radiology, SDM College of Dental Sciences, Dhanvad. Kamataka, India

Correspondence Address:
Manjunatha M Revanappa
Assistant Professor, Department of Oral Medicine and Radiology, College of Dental Sciences, Davangere, Kamataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.5005/jp-journals-10011-1311

Rights and Permissions

Objectives: Studies done on the management of oral lichen planus using tacrolimus are limited. The aim of the study is to compare the efficacy of tacrolimus with tramcinolone acetonide topically in the management of symptomatic oral lichen planus and also to evaluate adverse effects and opportunistic yeast infections. Materials and methods: A randomized controlled study was conducted on 60 patients with symptomatic lesions of oral lichen planus with biopsy proven who fulfilled the inclusion criteria. Study group comprised of 30 patients who received topical 0.1 tacrolimus in orabase therapy for 4 weeks. Control group comprised of 30 patients who received topical 0.1% triamcinolone acetonide in orabase for 4 weeks. Results: Significant improvement of symptoms (7.80 ΁ 1.90 to 1.2 ΁ 2.6) and clinical scores (3.1 ΁ 1.27 to 2.3 ΁ 1.1) in study group as compared to control group (7.60 ΁ 2.01 to 2.7 ΁ 2.5) and (2.73 ΁ 1.46 to 1.2 ΁ 1.4). No significant adverse effects were observed and no recurrence was noted during treatment and follow-up. Conclusion: Study group has shown significant clinical response (p = 0.002) when compared to control group. However, double-blind, controlled studies are needed to evaluate the efficacy of tacrolimus in the treatment of symptomatic oral lichen planus and to address the safety for long-term therapy.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed647    
    Printed15    
    Emailed0    
    PDF Downloaded169    
    Comments [Add]    

Recommend this journal